Invention Grant
- Patent Title: Solid state forms of fused heteroaromatic pyrrolidinones
-
Application No.: US16870653Application Date: 2020-05-08
-
Publication No.: US11352355B2Publication Date: 2022-06-07
- Inventor: Rongliang Chen , Tomonori Ichibakase , Chunrong Ma , Christopher F. Matthews , Hajime Motoyoshi , Colin O'Bryan , Kentaro Yaji , Naoki Yoshikawa
- Applicant: Calithera Biosciences, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Calithera Biosciences, Inc.
- Current Assignee: Calithera Biosciences, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Foley Hoag LLP
- Agent David. P. Halstead
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K9/20 ; A61K9/48
Abstract:
Disclosed are chemical entities which are inhibitors of spleen tyrosine kinase (SYK), namely, chemical entities comprising 6-((1R,2S)-2-aminocyclohexylamino)-7-fluoro-4-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,4-c]pyridine-3(2H)-one and certain solid state forms thereof. Also disclosed are methods of using the chemical entities to treat disorders such as a cancer.
Public/Granted literature
- US20200339573A1 SOLID STATE FORMS OF FUSED HETEROAROMATIC PYRROLIDINONES Public/Granted day:2020-10-29
Information query
